selfotel has been researched along with ly 233053 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, MB; Deeter, JB; Jones, ND; Leander, JD; Lodge, D; Ornstein, PL; Schoepp, DD | 1 |
| Leander, JD; Lodge, D; Ornstein, PL; Salhoff, CR; Schoepp, DD; Zeman, S; Zimmerman, DM | 1 |
| Clark, WM; Madden, KP; Zivin, JA | 1 |
3 other study(ies) available for selfotel and ly 233053
| Article | Year |
|---|---|
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer.
Topics: Animals; Animals, Newborn; Corpus Striatum; Mice; Molecular Structure; N-Methylaspartate; Nerve Degeneration; Pipecolic Acids; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Stereoisomerism; Structure-Activity Relationship; Tetrazoles; X-Ray Diffraction | 1992 |
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
Topics: Administration, Oral; Animals; Animals, Newborn; Behavior, Animal; Binding, Competitive; Dose-Response Relationship, Drug; Electroshock; Female; Injections, Intraperitoneal; Male; N-Methylaspartate; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles; Tritium | 1990 |
Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate antagonists in rabbits.
Topics: Animals; Ischemia; N-Methylaspartate; Paraplegia; Pipecolic Acids; Rabbits; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Tetrazoles; Time Factors | 1993 |